EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder

Siyu Mu iD, Kaiyue Zhao, Shanshan Zhong, Yanli Wang

Biomolecules · 22.08.2024 · 14 (8) · 1042

DOI: 10.3390/biom14081042 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.08.2024. Verfasst von Siyu Mu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang 110000, China. Hauptthemen laut MEDLINE: Adenosine, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6-methyladenosine (m6A) represents the most prevalent and significant internal modification in mRNA, with its critical role in gene expression regulation and cell fate determination increasingly recognized in recent research. The immune system, essential for defense against infections and maintaining internal stability through interactions with other bodily systems, is significantly influenced by m6A modification. This modification acts as a key post-transcriptional regulator of immune responses, though its effects on different immune cells vary across diseases. This review delineates the impact of m6A modification across major system-related cancers—including those of the respiratory, digestive, endocrine, nervous, urinary reproductive, musculoskeletal system malignancies, as well as acute myeloid leukemia and autoimmune diseases. We explore the pathogenic roles of m6A RNA modifications within the tumor immune microenvironment and the broader immune system, highlighting how RNA modification regulators interact with immune pathways during disease progression. Furthermore, we discuss how the expression patterns of these regulators can influence disease susceptibility to immunotherapy, facilitating the development of diagnostic and prognostic models and pioneering new therapeutic approaches. Overall, this review emphasizes the challenges and prospective directions of m6A-related immune regulation in various systemic diseases throughout the body.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineNeoplasmsHumansMethylationTumor MicroenvironmentAnimalsAutoimmune DiseasesImmune System Diseases

Stichwörter der Autor:innen

N6-methyladenosineRNA modificationimmune cellsimmunotherapytumor microenvironmenttumorigenesis

Substanzen

N-methyladenosineAdenosine

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang 110000, China.
  • Department of Hepatology, Beijing Tsinghua Changgeng Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
  • Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang 110000, China.

ORCID-Profile: Siyu Mu

Zitieren

APA

Mu, S., Zhao, K., Zhong, S., & Wang, Y. (2024). The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder. Biomolecules, 14(8), 1042. https://doi.org/10.3390/biom14081042

Vancouver

Mu S, Zhao K, Zhong S, Wang Y. The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder. Biomolecules. 2024;14(8):1042. doi:10.3390/biom14081042

BibTeX
@article{Mu2024,
  author = {Mu, Siyu and Zhao, Kaiyue and Zhong, Shanshan and Wang, Yanli},
  title = {The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {1042},
  doi = {10.3390/biom14081042}
}
Kostenlos starten →